Dr. Tricia Pendergrast, a recent Feinberg School of Medicine graduate who led the pre-COVID-19 study on harassment, recalled several responses from people who feared for their safety.
Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO.